Report Categories
View AllRecent Articles
View All
VERX Vertex posts narrow Q4 2025 EPS beat shares fall nearly 3 percent amid muted investor sentiment
Lexaria Bioscience LEXX retreats 5 despite EPS beating estimates by 38 with 52 revenue growth
GDVK The Series K cumulative preferred shares maintain 425 payout as quarterly update shows stable coverage ratios
DLXY Delixy CEO cites rising crossborder delivery demand as key bright spot in latest quarterly earnings report